through Reinforcement of Biomedical Science and Technology
Date: May 2007
Visit of EU partner, Prof Andrea Biondi, University of Milano-Bicocca, Milan, Italy. Prof Biondi is head of the M. Tettamanti Research Center for leukemia and hematological diseases of children and also head of S. Verri Cellular and Gene Therapy Laboratory, Hospital S. Gerardo, Monza. Furthermore he is the chairman of SIOP (International Society of Pediatric Oncology) Europe.
Prof Biondi has visited IMGGE, Laboratory for Molecular Hematology. He has checked the new equipment bought for HISERBS project. Partner 3 team and Prof Biondi have discussed important issues regarding Real -Time PCR (RQ PCR) methodology for detection of minimal residual disease of Chronic Myeloid Leukemia (CML), as well as RQ PCR evaluation the CML patient’s response to imatinib.
Prof Biondi has also attended the Project Committee Meeting and has suggested his engagement in introducing quality control assessment within HISERBS project.
Prof Biondi has given two lectures during his stay in Belgrade: Cellular Immunotherapy in Leukemia (IMGGE) and Molecular Basis of Childhood Leukemia (XV/I Congress of Pediatric Hematooncology in Serbia).
Prof Momcilo Jankovic (Hospital San Gerardo, Monza, Italy) and Prof Jan Stary (Department of Pediatrics, University Hospital Motol, Praha, Czech Republic) have accompanied Prof Andrea Biondi.
Date: Apr 2008
IMGGE has organized the visit of EU partner, Prof George P. Patrinos, Erasmus MC, Faculty of Medicine and Health Sciences, MGC-Department of Cell Biology and Genetics, Rotterdam, The Netherlands. Prof Patrinos is a head of Pharmacogenomics Group, Erasmus MC, Rotherdam. Furthermore he is the Editor of Haemoglobin. Prof Patrinos has visited IMGGE, Laboratory for Molecular Hematology. Prof Patrinos has given two lectures during his stay in Belgrade: Transcriptional Regulation of the Human beta-like Globin Genes and Locus-specific and National/Ethnic Mutation Databases in the Post-genomic Era.
Date: May 2008
As a part of the activities under EC FP6 project HISERBS Institute for Application of Nuclear Energy INEP held Open Day dedicated to Serum Tumor Markers on May 8, 2008. at 11.00 – 14.00 at INEP.
Date: May 2008
Institute of Molecular Genetics and Genetic Engineering (IMGGE), Belgrade and Institute of Medical Research (IMR), Belgrade have organized an Open Day dedicated to Molecular Markers in Diagnostics and Follow-up of Hematological Malignancies. The Open Day was held at the IMGGE, on May, 28th, 2008. The meeting of Hematology Section of the Serbian Medical Association was held at the same time. The HISERBS project results were presented on that meeting.
Date: December 2008
Department of Biochemistry and Molecular Biology, Faculty of Biology, University of Athens, Panepistimiopolis, Athens, Greece is one of the EU partner institution of the HISERBS Project, with Prof Andreas Scorilas, as its representative. Prof Andreas Scorilas has recently visited IMGGE, Belgrade, in order to discuss with the group of Dr Sonja Pavlovic, the scientific results of the collaborative work and the publication of the data obtained.
Date: November 13-15, 2008. Belgrade
HISERBS project achievements have been presented at the Meeting “45th Oncology Week” , organized by Oncology Section of the Serbian Medical Society.
Date: May 14-17, 2009. Cavtat, Croatia 8th Balkan Meeting on Human Genetics
http://www.studiohrg.hr/human-genetics2009/
HISERBS project has organized
Round Table entitled
Molecular Markers in Detection and Follow-up of Malignancies:
FP6 HISERBS Project Experience
Moderators: Milenković P, Vićovac Lj, Pavlović S.
Presentations:
FP6 project HISERBS (Health Improvement in Serbia through
Reinforcement of Biomedical Science and Technology)
Pavle Milenković,
Institute for Medical Research (IMR), University of Belgrade, Belgrade, Serbia
Cancer Cell Phenotype Markers
Ljiljana Vićovac, Institute for Application of Nuclear Energy (INEP),
University of Belgrade, Belgrade, Serbia
Modern Methodology in Detection and Follow-up
of BCR-ABL and PML-RARalpha Fusion Gene Transcripts in Leukemia
Nataša Tošić, Institute of Molecular Genetics and Genetic Engineering
(IMGGE),
University of Belgrade, Belgrade,
Serbia
Molecular Characterization of the Most Common
Single Gene Mutations (FLT3, NPM1, JAK2) in Hematological Malignancies
Sonja Pavlović, Institute of Molecular Genetics and Genetic Engineering
(IMGGE),
University of Belgrade, Belgrade,
Serbia
Gene Expression Profiling of Hematopoietic Progenitor Cells in
Myeloproliferative Disorders
Vladan Čokić,
Institute for Medical Research
(IMR), University of Belgrade, Belgrade, Serbia
Predictive, Preventive and Personalized Medicine Network in
Europe (EPMA)
Dragica Radojković, Institute of Molecular Genetics and Genetic Engineering
(IMGGE),
University of Belgrade, Belgrade,
Serbia
Regulation of the p53 Tumor Suppressor by Ribosomal Proteins
Siniša Volarević, Department of Molecular Medicine and Biotechnology, School of
Medicine, University of Rijeka, Rijeka, Croatia
Panel discussion
The visit to INEP by Richard Harvey, PhD, Charing Cross Hospital, London, UK, Department of Medical Oncology Laboratory, June 14-21 2009. The Department of Medical Oncology of the Charing Cross Hospital, London, has become one of the most significant EU collaborators for INEP, whose interest lies specifically in the field of serum markers for malignant diseases. Department of Medical Oncology Laboratory is a very busy lab since it is a UK reference laboratory for gestational trophoblast diseases (GTDs), among other malignancies. GTDs are being monitored by the presence of serum hCG.
Dr Richard Harvey came to INEP as a representative of the Department of Medical Oncology Laboratory, being a person involved in managing and running the laboratory and with considerable practical experience in the tests being used as part of the dayly routine.
